Paper159309
Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
Zeller WJ and 2 others. J Cancer Res Clin Oncol, 1979. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222. Papers, record 159309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/159309
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Experimental | Major topic |
| Nitrosourea Compounds | Major topic |
| Animals | |
| Carmustine | |
| Drug Evaluation, Preclinical | |
| Female | |
| Lomustine | |
| Male | |
| Rats | |
| Semustine | |
| Streptozocin |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1120307 | Chemotherapy of the transplantable acute leukemia L5222 in rats. | Cancer Res | 1975 | https://conductscience.org/library/papers/1120307 | PubMed |
| 2 | 4829828 | [Leukemia L 5222 of the rat strain BD IX. An ethylnitrosourea-induced monocytic-myeloic transplantable form for cytochemical and chemotherapeutic studies]. | Blut | 1974 | https://conductscience.org/library/papers/4829828 | PubMed |
| 3 | 122802 | Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin. | J Med Chem | 1975 | https://conductscience.org/library/papers/122802 | PubMed |
| 4 | 954014 | The nitrosoureas--thoughts for the future. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/954014 | PubMed |
| 5 | 136102 | Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1976 | https://conductscience.org/library/papers/136102 | PubMed |
| 6 | 621753 | Chemotherapeutic activity of new 2-chloroethylnitrosoureas in rat L5222 leukemia: comparison of bifunctional and water-soluble derivatives with 1,3-bis(2-chloroethyl)-1-nitrosourea. | J Natl Cancer Inst | 1978 | https://conductscience.org/library/papers/621753 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7309781 | Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/7309781 | PubMed |
| 6771294 | Chemotherapy of autochthonous leukemias induced by 7,12-dimethylbenz(a)anthracene in Long Evans rats. | J Cancer Res Clin Oncol | 1980 | https://conductscience.org/library/papers/6771294 | PubMed |
| 6470033 | Antineoplastic activity of esters and amides of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-aminoacids. | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6470033 | PubMed |
| 6227420 | Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6227420 | PubMed |
| 3733867 | Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC). | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/3733867 | PubMed |
| 3700459 | New derivatives of CNC-amino acids and -oligopeptides: experimental antitumor activity. | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/3700459 | PubMed |
| 3536942 | DNA adducts and DNA damage by antineoplastic and carcinogenic N-nitrosocompounds. | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/3536942 | PubMed |
| 2930696 | Anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine, glycine, their di- and tripeptide homologues and the respective amides in methylnitrosourea-induced rat mammary carcinoma. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2930696 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/159309
GET https://conductscience.org/api/papers/v1/159309/authors